Roche NimbleGen has announced the launch of comparative genomic hybridization (CGH) arrays and services for the high-resolution mapping of genomic copy-number differences based on the company’s new ...

Clinical testing using various array comparative genomic hybridization platforms is being incorporated rapidly into cytogenetic testing algorithms. Comprehensive validation of these complex assays ...

Array comparative genomic hybridization (CGH) is illuminating DNA copy number variations (CNV) throughout the genome to diagnose disease etiology and to help tailor treatment regimens for patients to ...

Purpose: The goal of this work was to test the ability of oligonucleotide-based arrays to reproduce the results of focused bacterial artificial chromosome (BAC)-based arrays used clinically in ...

Comparative genomic hybridization (CGH) was developed to identify pathogenic DNA copy-number changes (e.g., duplications, deletions) on a genome-wide scale, and to map these changes to genomic ...

Comparative genomic hybridisation array:- What is the effectiveness and acceptability of comparative genomic hybridisation (CGH) array compared with current genetic testing in children and young ...